Form 8-K - Current report:
SEC Accession No. 0001437749-25-023521
Filing Date
2025-07-25
Accepted
2025-07-25 16:07:31
Documents
13
Period of Report
2025-07-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K veru20250724c_8k.htm   iXBRL 8-K 29660
  Complete submission text file 0001437749-25-023521.txt   159543

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA veru-20250725.xsd EX-101.SCH 3580
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE veru-20250725_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE veru-20250725_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE veru-20250725_pre.xml EX-101.PRE 11585
15 EXTRACTED XBRL INSTANCE DOCUMENT veru20250724c_8k_htm.xml XML 2831
Mailing Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127
Business Address 2916 N. MIAMI AVENUE SUITE 1000 MIAMI FL 33127 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

EIN.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-13602 | Film No.: 251151756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)